Covid-19: Germans advance on vaccine and treatment

The results of phase 1 of the vaccine candidate developed by the German biotech CureVac showed an immune response in humans. At the same time, a treatment developed by other German researchers has made it possible to limit the replication of the coronavirus in vitro.